CARTER-WALLACE v. Gillette Co., Civ. A. No. 77-3186-MA.

Citation540 F. Supp. 1324
Decision Date15 June 1982
Docket NumberCiv. A. No. 77-3186-MA.
PartiesCARTER-WALLACE, INC., Plaintiff, v. The GILLETTE COMPANY, Defendant.
CourtU.S. District Court — District of Massachusetts

Herbert P. Kenway, Kenway & Jenney, Boston, Mass., for plaintiff.

Robert W. Furlong, Gregory A. Madera, and Frank P. Porcelli, Fish & Richardson, Boston, Mass., for defendant.

SUPPLEMENTAL OPINION

MAZZONE, District Judge.

This matter was remanded to this Court to reconsider its finding of obviousness without giving any weight to the fact that the formula was arrived at by experimentation rather than inventive genius. Carter-Wallace, Inc. v. The Gillette Company, 675 F.2d 10, at 15 (1st Cir. 1982). I was also advised to review my finding on criticality as well because it was so intertwined with the obviousness issue. My original opinion was reported at 531 F.Supp. 840 (D.Mass. 1981).

The primary basis on which my opinion rested was the failure of Carter-Wallace to establish the criticality of the numerical limits of the patent in suit. Although the issue of criticality was subsumed in the discussion of obviousness, criticality was analytically distinct and so approached in the opinion. The line of cases beginning with Helene Curtis Industries, Inc., et al. v. Sales Affiliates, Inc., et al., 233 F.2d 148, 152 (2d Cir.), cert. denied, 352 U.S. 879, 77 S.Ct. 101, 1 L.Ed.2d 80 (1956) and Kwik Set, Inc. v. Welch Grape Juice Co., 86 F.2d 945, 947 (2d Cir. 1936), persuaded me that, in order to be patentable, a combination, such as the one described in the patent in suit, involving known ingredients performing their usual functions must achieve a result different in kind rather than degree from the prior art. See 531 F.Supp. at 867-70, and cases cited. As I indicated in the opinion, neither inventor had been able to explain how the numerical limits of the patent in suit were determined. 531 F.Supp. at 869. In addition, no test data were introduced by Carter-Wallace to establish the criticality of those limits. Id. Under these circumstances, a finding of lack of criticality was required. My finding on this point was unaffected by the manner in which the Arrid formulation was developed and, in my judgment, was sufficient to support my invalidation of the patent in suit.

I regarded the discussion about obviousness that followed as unnecessary to my conclusion on the issue of validity. I attempted in that discussion to point out, not that the Spitzer formulation was unpatentable simply because it came about as a result of trial and error experimentation, but that the very process of routine experimentation which the inventors followed in this case had been rendered obvious by the teachings of the prior art. For example, as stated in the section of my opinion entitled: "THE TEACHINGS OF THE PRIOR ART," 531 F.Supp. at 851, the prior art (Yakubik in particular), taught that the relative concentrations of powder and oil in aerosol compositions was largely a matter of personal preference and that, in general, the use of oil in higher concentrations produced a wet, oily spray. The inventors in this case acknowledged that the selection of various proportions of oil and powder in their test formulations was largely motivated by considerations of consumer preference—precisely as had been suggested by Yakubik. See 531 F.Supp. at 853-54. In short, the very process of routine experimentation which led to the invention had been suggested by the prior art,1 a point I wished to make, but which was added only for the purpose of clarity and upon which I placed no significant weight in reaching my decision.

Of the factors which led me to the finding of obviousness, the "routine experimentation"...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT